PathoQuest will be attending the upcoming 4th NeoAg Summit being held in Boston, Massachusetts on 20 to 22 November. This is the only only industry-focused meeting dedicated solely to the full end-to-end development and commercialization of neoantigen-based cancer immunotherapies.

Contact us in advance to prearrange a meeting with PathoQuest representatives to discuss the broad range of NGS testing applications we offer. 

PathoQuest is “Your genomic expert for biologics testing”

.